AI-generated summary
This review summarizes recent research on repeated low-level red light therapy as a nonpharmacological approach to slow myopia progression. The authors outline putative mechanisms and synthesize efficacy and parameter evidence from animal and randomized clinical studies. They report that the treatment is generally well tolerated in the short term, while long-term retinal structural effects and dose-related safety remain debated.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract states that long-term retinal structural effects and dose-related safety boundaries remain debated and that longer follow-up is needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Myopia, Red light therapy, Nitric oxide, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.